Clinical Trial Update: Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing exposure of FX006 vs TAcs in patients with bilateral knee osteoarthritis has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bilateral Knee Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• FX006
• tACS

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Bilateral Knee Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-01